|
|
| | 2-Bromo-4-pyridinecarboxaldehyde Basic information |
| | 2-Bromo-4-pyridinecarboxaldehyde Chemical Properties |
| Melting point | 52-56°C | | Boiling point | 272.9±20.0 °C(Predicted) | | density | 1.683±0.06 g/cm3(Predicted) | | storage temp. | Inert atmosphere,2-8°C | | solubility | soluble in Acetone | | form | Crystalline Powder | | pka | -1.18±0.10(Predicted) | | color | Pale yellow | | Sensitive | Air Sensitive | | BRN | 4243166 | | InChI | 1S/C6H4BrNO/c7-6-3-5(4-9)1-2-8-6/h1-4H | | InChIKey | RTWLIQFKXMWEJY-UHFFFAOYSA-N | | SMILES | Brc1cc(C=O)ccn1 | | CAS DataBase Reference | 118289-17-1(CAS DataBase Reference) |
| Hazard Codes | Xi,Xn,F | | Risk Statements | 36/37/38-20/21/22-10-22 | | Safety Statements | 26-36/37/39-16 | | WGK Germany | 3 | | HazardClass | IRRITANT | | HS Code | 29333990 | | Storage Class | 11 - Combustible Solids | | Hazard Classifications | Acute Tox. 4 Oral Eye Irrit. 2 Skin Irrit. 2 STOT SE 3 |
| Provider | Language |
|
ALFA
| English |
| | 2-Bromo-4-pyridinecarboxaldehyde Usage And Synthesis |
| Uses | 2-Bromo-4-pyridinecarboxaldehyde is a pharmaceutical intermediate ingredient used in the synthesis of Lafutidine, a histamine H2 receptor antagonist used in the treatment of gastrointestinal disorders such as gastroesophageal reflux disease (acid reflux) and peptic ulcer disease. |
| | 2-Bromo-4-pyridinecarboxaldehyde Preparation Products And Raw materials |
|